INTRODUCTION
rates occurring in Asia and Africa. 2 Overall, the mortality incidence ratio of endometrial cancer is 26%, and it was responsible for 73,854 deaths in 2008. 1 This cancer rise sharply in occurrence during the perimenopausal years and peak well after the menopause. 3 Ninety percent of cases occur in women older than 50 years, and the median age at diagnosis is 62 years. [1] [2] [3] [4] Most women are being diagnosed because of irregular vaginal bleeding and roughly 76% of women survive for 5 years. 5 Diagnosis of endometrial cancer is confirmed by endometrial biopsy via dilatation and curettage (D&C). 5 A diagnosis of endometrial cancer must be obtained before staging or treatment that confirms the cancer, identifies the histological type and grade. 5, 6 Treatment strategy is determined by classifed risk of recurrence, which is defined by stage, histological type, and grade according to European Society for Medical Oncology (ESMO) risk classification 2009. Surgery is the standard treatment for endometrial cancer patient. Others additional operative procedures, such as lymphadenectomy and/ or omentectomy are performed based on clinical stage, histological type, and grade. [5] [6] [7] Based on histopathology, endometrial cancer is divided into two categories, type I is endometrioid tumors which suggested that the multistep carcinogenicprocess of type 1 endometrial tumors begins with simple endometrial hyperplasia, progresses to complex atypia hyperplasia, and then develops into the precursor lesion, endometrial intraepithelial neoplasia (EIN). Type 2 or nonendometrioid tumors, encompasses the remaining 10-20% of sporadic endometrial tumors. Histologies of type 2 are uterine papillary serous carcinoma (UPSC), clearcell carcinoma and carcinosarcoma. 5, 8 Myometrial invasion depth is a predictor of recurrence, and important in the decision making for adjuvant treatment. 9, 10 According to the FIGO staging system, myometrial invasion depth is expressed as invasion of < 2 of the myometrium and ≥2 of the myometrium. 9, 11 Preoperative radiologic testing using ultrasound, computed tomography, or magnetic resonance imaging is suboptimal in identifying patients with pelvic or paraaortic nodal metastases and to examine myometrial invasion. 12, 13 Patients with low risk endometrial cancers or intra operatively assessed with no lymph node metastases are not considered for pelvic and para-aortic lymphadenectomy for surgical staging. 14, 15 Meanwhile, in intermediate risk patient, the usefulness of lymphadenectomy is still debating, and pelvic lymphadenectomy is not recommended, unless for stage IB grade 2 or stage IA grade 3 with myometrial involvement. 5 Para-aortic and iliac lymphadenectomy is recommended in high risk endometrial cancers. 5 The objective of this study is to evaluate preoperative endometrial cancer risk of recurrence, based on dilatation and curettage (D&C) histopathological and ultrasonographic findings, to their postoperative histopathological findings. Demographic characteristics of patients was shown in Table 1 . Patients' age ranges from 34 to 79 years old. There were 40 menopausal patients (54.7%) whose age ranges from 41 to 58 years old, and 33 premenopausal patients (45.3%) whose age ranges from 34 to 40 years old. Patient's parity range from 0 to 10 parities, with mean parity was 3 parities. Regarding body mass index, there were 5 underweight patients (6.8%), 22 normal patients (30.1%), 10 overweight patients (13.6%), 24 obese grade I patients (32.8%) and 12 obese grade II patients (16.7%). 
METHODS

Demographic Characteristics n = 73 %
Age
• Median 53
• Minimum 34
• Maximum 79
Parities
• Mean 3
• Minimum 0
• Maximum 10 Menopausal Age
• Median 51
• Minimum 41
• Maximum 58
Body Mass Index
• Underweight 5 6.8
• Normal 22 30.1
• Overweight 10 13.6
• Obese I 24 32.8
• Either from D&C or postoperative histopathological findings showed that Endometrioid Adenocarcinoma was the most detected histological type from, 62 patients and 60 patients (84.9% and 82.1%). From 62 Endometrioid Adenocarcinoma (84.9%) assessed from D&C, there were 6 patients (9.6%) which had different final histological type result. The other D&C histological types showed no different findings referred to postoperative histological types. (Table 2 ) Endometrial cancer grade, based on D&C histopathological reports, was evenly distributed. But, when it comes from postoperative histopathological reports, grade II was the commonest found (42.4%).
From 73 patients assessed by ultrasonography examination, showed 23 patients (31.5%) with < 2 myometrial invasion and 50 patients (68.5%) with ≥ 2 myometrial invasion. There were 27 patients (36.9%) identified by postoperative pathological finding showed different myometrial invasion result compared to ultrasonography examination. Lymph node of < 2 myometrial invasion (based on ultrasonographic) was evaluated in 12 patients (52.1%), and only 7 patients (58.3%) with positive lymph nodes metastases, and 11 patients (47.9%) without evaluation of lymph node because lymphadenectomy was not performed in these patients. Group with ≥ 2 myometrial invasion had 39 patients (78%) with lymphadenectomy, and 22 patients (44%) of them had positive lymph node metastases. Eleven patients (22%) were not performed lymphadenectomy. 
DISCUSSION
Endometrial cancer is the most common gynecological cancer affecting postmenopausal women. Endometrial cancer most commonly affects women between 50 -65 years old. 3, 17 Those reports were consistent with our study. However, the difference between postmenopausal women (54.8%) and premenopausal women (45.2%) in our study is not prominent. Menstrual factors, early age at menarche and late age at menopause, contribute for development of endometrial cancer. 3 In this study age at menarche was not observed, because of lack information regarding patient's menarche, especially data from postmenopausal women group. Patients' The other risk factor contributing to endometrial cancer is nulliparity which in our study accounted for 30.1% of all patients. 3, 17 Patients' parity ranges from 0 to 10 parities and the mean value is 3 parities. Nulliparity increase the rate the risk of endometrial cancer two to three times compared with non-nulliparity group, and also the risk is decreasing with increasing number of children. Infertility also associated with increasing risk of endometrial cancer, such as polycystic ovary syndrome. 3 Several studies reported that endometrial cancer is associated with obesity. Obesity increases endometrial cancer risk 3-fold independently compared to non-obese women. 18 Central or upperbody is more important the measurement pheral body adiposity specially measurement of central adiposity after adjustment of BMI, to measure risk of endometrial cancer. 3, [19] [20] [21] In our report, obese women (BMI ≥ 25kg/m 2 ) accounted for 39.5% of all patients which consist of 32.8% obese grade 1 (BMI 25-29.9 kg/m 2 ) and 16.7% obese grade 2 (BMI ≥ 30 kg/m 2 ). The distribution of endometrial cancer in normal BMI (18.5-24.9 kg/m 2 ) patient was 30.1% which was not much different in number with obese grade I patient. Obesity associated with increasing of endometrial cancer could be biologically explained. Postmenopausal obese women have higher endogenous level of estrogen compared to lean women due to amortization of androstenedione in adipose tissue. 3, 18 Based on histopathological finding, approximately 80% of endometrial cancer were type I (endometrioid) with well to moderate differentiation which were confined to the uterine corpus at diagnosis. High grade type II endometrial cancer accounted for only 15% to 20% of cases. 8 In our study, endometrial cancer type I accounted for 82.1% cases based on D&C results, and 84.9% based on histopathological finding. There were 9.6% patients diagnosed with endometrial cancer type I based on D&C result had different postoperative histopathological result. It indicates the D&C examination in our hospital is reliable to determine endometrial cancer histological type.
Meanwhile, differentiation of endometrial cancer based on postoperative histopathological result shows 50.6% discrepancy compared to D&C result. We found that poor differentiation based on D&C result had the most discrepancy (56.5%) compare to other differentiation.
Myometrial invasion preoperative assessment based on ultrasonographic findings is used for determining endometrial cancer risk and planning surgical procedures. 10, 22 Our study collected < 2 myometrial invasion based on ultrasonography findings had 60.8% discrepancy compared to postoperative histopathological finding. Meanwhile, ≥ 2 myometrial invasion based on ultrasonography had 26% discrepancy. Our finding is consistent with study conducted by Sato et al, preoperative myometrial invasion depth based on ultrasonography gives inconsistent result compared to postoperative histopathological finding. 22 Myometrial invasion depth helps clinicians make decisions during operation to do or not to do lymphadenectomy. 12, 14, 23 According to our finding, in ≥ 2 myometrial invasion group (based on ultrasonographic examination), only 78% cases were performed lymphadenectomy procedure. Meanwhile, in < 2 myometrial invasion (postoperative histopathological finding) group, lymphadenectomy was performed in 52.1% cases. It showed lymphadenectomy is performed not only based on myometrial invasion depth, but also based on intraoperative assessment of suspicious enlarged lymphnode.
Endometrial cancer risk were determined by histological type, grade and myometrial invasion according to European Society for Medical Oncology (ESMO) 2009. 5 This risk classification aim to determine recurrence, additional procedures (lymphadenectomy and/or omentectomy), and adjuvant therapy. 5 5 In our study, 75% of low risk endometrial cancer patients' lymph nodes was not assessed. Only 25% of them were assessed because of intraoperative assessment of suspicious enlarged lymph node. However, the lymph node pathological assessment returned with negative result. Intermediate risk endometrial cancer patient underwent pelvic and/or paraaorta lymphadenectomy for 74% cases, only 40% of all the patients had positive lymph node metastases. From 82.3% high risk patients underwent pelvic and/or paraaorta lymphadenectomy, 58.8% had positive lymph node metastases. According to this finding, high risk endometrial cancer patient had the most positive lymph node result compared to other risks. Moreover, increasing risk classification showed more positive lymph node metastases.
Most of the patients were finally diagnosed with Stage IIIC (35.6%) endometrial cancer. However, most of the patients were diagnosed with early stage endometrial cancer (50.6%). Endometrial cancer risks compared to FIGO stage showed the higher the risk patient had, the more advanced the stage were.
CONCLUSION
Most of the patients with endometrial cancer were preoperatively diagnosed as high risk group. The commonest of the stage after surgical histopathological examination were stage IIIC. High risk of recurrence endometrial cancer showed more positive lymph node compared to low or intermediate risk of recurrence. Histopathological findings based on D&C examination showed inconsistent results compared to postoperative histopathological findings. Myometrial invasion findings based on ultrasonography compared to postoperative findings showed inconsistent results. Patients with ≥ 2 myometrial invasion had more positive lymph nodes metastases compared to < 2 myometrial invasion. Endometrial cancer risks compared to FIGO stage showed the higher the risk patient had, the more advanced the stage were.
